Inhibitory Effects of Alkaloids on OATP1B1 In Vitro and In Vivo: Prediction for Food/Herb–Drug Interactions and Hepatoprotective Effects Based on Structure–Activity Relationships
Chemical Research in Toxicology · 2025
DOI: 10.1021/acs.chemrestox.4c00418 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2025. Verfasst von Yanhong Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study…. Hauptthemen laut MEDLINE: Alkaloids, Organic Anion Transporters, Protective Agents, Drugs, Chinese Herbal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences Initiative for Innovative Medicine.
Abstract (Originalsprache)
Alkaloids, a class of low-molecular-weight nitrogenous compounds, attract a great deal of interest because of their biological activities and therapeutic potential. Yet, surprisingly little is known about their interactions with drug transporters, especially Organic Anion Transporting Polypeptide 1B1 (OATP1B1), a liver-specific uptake transporter, which is closely associated with drug-induced liver injury (DILI). This study aims to investigate the inhibitory effects of 160 alkaloids on OATP1B1, assess the hepatoprotective effects against bosentan-induced liver injury, and elucidate the structure-activity relationships of alkaloids with OATP1B1. Four alkaloids, including dihydroberberine, deacetyltaxol, dihydrocapsaicin, and tetrahydropalmatine, significantly inhibited OATP1B1 transport activity in OATP1B1-HEK293 cells (>50%), which reduced the OATP1B1-mediated uptake of methotrexate and microcystin-LR, and consequently decreased their cell toxicity. In bosentan-induced liver injury models, 4 alkaloids reduced serum total bile acid (TBA) levels and liver concentration of bosentan to different degrees, especially deacetyltaxol, which exhibited the most potent hepatoprotective effect against bosentan. The pharmacophore model suggested that the critical pharmacophores of alkaloid inhibitors are hydrogen bond acceptors and hydrophobic groups. Our findings pave the way for predicting the potential risks of alkaloids-containing food/herb-drug interactions in humans and optimizing the alkaloid structure for alleviating OATP1B1-related DILI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study, Beijing Key Laboratory of Active Substances Discovery and Drug Abili…
- Department of Pharmacy, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
ORCID-Profile: Jinping Hu
Förderung
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
Zitieren
APA
Sun, Y., Tan, H., Wang, F., Hu, J., Duan, X., Bai, W., Wu, J., Bai, J., & Hu, J. (2025). Inhibitory Effects of Alkaloids on OATP1B1 In Vitro and In Vivo: Prediction for Food/Herb–Drug Interactions and Hepatoprotective Effects Based on Structure–Activity Relationships. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.4c00418
Vancouver
Sun Y, Tan H, Wang F, Hu J, Duan X, Bai W, et al. Inhibitory Effects of Alkaloids on OATP1B1 In Vitro and In Vivo: Prediction for Food/Herb–Drug Interactions and Hepatoprotective Effects Based on Structure–Activity Relationships. Chemical Research in Toxicology. 2025. doi:10.1021/acs.chemrestox.4c00418
BibTeX
@article{Sun2025,
author = {Sun, Yanhong and Tan, Huixin and Wang, Fenghe and Hu, Jiahuan and Duan, Xiaoyan and Bai, Wanting and Wu, Jinjin and Bai, Jie and Hu, Jinping},
title = {Inhibitory Effects of Alkaloids on OATP1B1 In Vitro and In Vivo: Prediction for Food/Herb–Drug Interactions and Hepatoprotective Effects Based on Structure–Activity Relationships},
journal = {Chemical Research in Toxicology},
year = {2025},
doi = {10.1021/acs.chemrestox.4c00418}
}
EUVIMED